But the carriers of the PRKN–PACRG C-G-T-G-C-T-C-A-T-C-T and C-G-T-G-T-T-C-A-T-C-T decreased the risk of hyperlipidaemia (adjusted OR = 0.172, 95% CI = 0.116–0.645, P < 0.001). Here, PRKN is linked to hyperlipidemia.